Clinical Trials Directory

Trials / Completed

CompletedNCT01285752

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Asahi Kasei Therapeutics Corporation · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To investigate the efficacy and safety of AK106-001616 in patients with rheumatoid arthritis.

Conditions

Interventions

TypeNameDescription
DRUGAK106-001616
DRUGAK106-001616
DRUGActive comparator

Timeline

Start date
2011-02-01
Primary completion
2012-01-01
Completion
2012-12-01
First posted
2011-01-28
Last updated
2016-07-25

Locations

26 sites across 7 countries: Czechia, Germany, Hungary, Poland, Slovakia, Ukraine, United Kingdom

Source: ClinicalTrials.gov record NCT01285752. Inclusion in this directory is not an endorsement.

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) (NCT01285752) · Clinical Trials Directory